menu
Your Cart

ITT5893

ITT5893-3
ITT5893-5
ITT5893-2
ITT5893-4
ITT5893
ITT5893-3
ITT5893-5
ITT5893-2
ITT5893-4
ITT5893
ITT5893
  • Catalog: ITT5893
  • Gene/Protein: TGFB2
  • Product Description: Immunotag™ TGFβ2 Polyclonal Antibody
385.0000
Price in reward points: 385

Available Options

Immunotag™ TGFβ2 Polyclonal Antibody
Antibody Specification
Datasheet
Target Protein TGFβ2
Clonality Polyclonal
Storage/Stability -20°C/1 year
Application WB,IHC-p,ELISA
Recommended Dilution WB 1:500-2000,IHC-p 1:500-200, ELISA 1:10000-20000
Concentration 1 mg/ml
Reactive Species Human,Mouse,Rat
Host Species Rabbit
Immunogen Synthetic peptide from human protein at AA range: 61-110
Specificity The antibody detects endogenous TGFβ2
Purification The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen
Form Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
Gene Name TGFB2
Accession No. P61812 P27090 Q07257
Alternate Names Transforming growth factor beta-2 (TGF-beta-2) (BSC-1 cell growth inhibitor) (Cetermin) (Glioblastoma-derived T-cell suppressor factor) (G-TSF) (Polyergin)
Description transforming growth factor beta 2(TGFB2) Homo sapiens This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate a latency-associated peptide (LAP) and a mature peptide, and is found in either a latent form composed of a mature peptide homodimer, a LAP homodimer, and a latent TGF-beta binding protein, or in an active form consisting solely of the mature peptide homodimer. The mature peptide may also form heterodimers with other TGF-beta family members. Disruption of the TGF-beta/SMAD pathway has been implicated in a variety of human cancers. A chromosomal translocation that includes this gene is associated with Peters' anomaly, a congenital defect of the an
Cell Pathway/ Category MAPK_ERK_Growth,MAPK_G_Protein,Cytokine-cytokine receptor interaction,Cell_Cycle_G1S,Cell_Cycle_G2M_DNA,TGF-beta,Intestinal immune network for IgA production,Pathways in cancer,Colorectal cancer,Renal cell carcinoma,Pancreatic cancer,Chronic myeloid leukemia,Hypertrophic cardiomyopathy (HCM),Dilated cardiomyopathy,
Protein Expression Aorta endothelial cell,Lung,
Subcellular Localization extracellular region,extracellular space,endosome,axon,extracellular matrix,platelet alpha granule lumen,neuronal cell body,
Protein Function disease:A chromosomal aberration involving TGFB2 is found in a family with Peters anomaly [MIM:604229]. Translocation t(1;7)(q41;p21) with HDAC9. Peters anomaly consists of a central corneal leukoma, absence of the posterior corneal stroma and Descemet membrane, and a variable degree of iris and lenticular attachments to the central aspect of the posterior cornea.,function:TGF-beta 2 has suppressive effects on interleukin-2 dependent T-cell growth.,online information:TGF beta-2 entry,similarity:Belongs to the TGF-beta family.,subunit:Homodimer; disulfide-linked.,
Usage For Research Use Only! Not for diagnostic or therapeutic procedures.
Material Safety Data Sheet
English_US
Danish
Dutch
English_UK
French
German
Spanish
Norwegian
Portuguese
Finnish
Swedish
Polish

Write a review

Note: HTML is not translated!
Bad Good
Captcha

CONNECT WITH US